These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33029353)

  • 1. A rapid assessment of the National Regulatory Systems for medical products in the Southern African Development Community.
    Dube-Mwedzi S; Kniazkov S; Nikiema JB; Kasilo OMJ; Fortin A; Tumusiime P; Mahlangu GN; Ndomondo-Sigonda M
    J Pharm Policy Pract; 2020; 13():64. PubMed ID: 33029353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention, Detection and Response to incidences of substandard and falsified medical products in the Member States of the Southern African Development Community.
    Kniazkov S; Dube-Mwedzi S; Nikiema JB
    J Pharm Policy Pract; 2020; 13():71. PubMed ID: 33088577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization of medical products regulation: a key factor for improving regulatory capacity in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Masota NE; Ng'andu B; Ngum N; Kaale E
    BMC Public Health; 2021 Jan; 21(1):187. PubMed ID: 33478421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of pharmacovigilance guidelines in the Southern African Development Community: A document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5755. PubMed ID: 38362654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
    Makhene NL; Steyn H; Vorster M; Lubbe MS; Burger JR
    Ther Adv Drug Saf; 2023; 14():20420986221143272. PubMed ID: 36713000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer packaging labelling of medicines in Southern African Development Community (SADC) countries: comparative analysis of requirements and transition terms for harmonisation.
    Narsai K; Masekela FB; Leufkens HGM; Mantel-Teeuwisse AK
    BMC Health Serv Res; 2024 Jan; 24(1):111. PubMed ID: 38245720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National medicines regulatory authorities financial sustainability in the East African Community.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Ng'andu B; Ngum N; Masota NE; Kaale E
    PLoS One; 2020; 15(7):e0236332. PubMed ID: 32702048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A desktop review of evaluation of implementation of national medicines policies in SADC countries.
    Modiba WK; Katerere DR; Mncwangi NP
    Heliyon; 2023 Nov; 9(11):e22218. PubMed ID: 38045165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of the African Medicines Agency: progress, challenges and regulatory readiness.
    Ncube BM; Dube A; Ward K
    J Pharm Policy Pract; 2021 Mar; 14(1):29. PubMed ID: 33685518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medicines Regulation in Africa: Current State and Opportunities.
    Ndomondo-Sigonda M; Miot J; Naidoo S; Dodoo A; Kaale E
    Pharmaceut Med; 2017; 31(6):383-397. PubMed ID: 29200865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Situation analysis on the regulation of nanomedicines in Southern Africa.
    Mudyiwenyama LG; Khoza S; Dube A
    Front Med (Lausanne); 2023; 10():1098830. PubMed ID: 37153083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WHO-listed authorities (WLA) framework: transparent evidence-based approach for promoting regulatory reliance towards increased access to quality-assured medical products.
    Broojerdi AK; Salvati AL; Abdelfattah MR; Dehaghi ROA; Sillo HB; Gaspar R
    Front Med (Lausanne); 2024; 11():1467229. PubMed ID: 39376648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges.
    Ncube BM; Dube A; Ward K
    Front Med (Lausanne); 2023; 10():1117439. PubMed ID: 36793874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Legislative landscape for traditional health practitioners in Southern African development community countries: a scoping review.
    Abrams AL; Falkenberg T; Rautenbach C; Moshabela M; Shezi B; van Ellewee S; Street R
    BMJ Open; 2020 Jan; 10(1):e029958. PubMed ID: 31915157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importation and distribution of unregistered medicines in the public sector: similarities, differences, and shared challenges among Southern African Development Community (SADC) countries.
    Nyika A; Ngara B; Mutingwende I; Gwaza L
    BMC Health Serv Res; 2022 Apr; 22(1):570. PubMed ID: 35484525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment.
    Sithole T; Ngum N; Owusu-Asante M; Walker S; Salek S
    Int J Health Policy Manag; 2024; 13():8070. PubMed ID: 39099506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Best practices in the African Medicines Regulatory Harmonization initiative: Perspectives of regulators and medicines manufacturers.
    Ndomondo-Sigonda M; Azatyan S; Doerr P; Agaba C; Harper KN
    PLOS Glob Public Health; 2023; 3(4):e0001651. PubMed ID: 37186241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries.
    Shabangu PP; Kuwana RJ; Dube A
    Front Med (Lausanne); 2022; 9():975032. PubMed ID: 36160156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Making the investment case for national regulatory authorities.
    Twesigye G; Hafner T; Guzman J
    J Pharm Policy Pract; 2021 Jan; 14(1):16. PubMed ID: 33478590
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.